加科思藥業集團有限公司（股票代码：01167）于2026年10月6日发布2026年9月的股份变动月报表。报告显示，截至2026年9月30日，公司法定注册股本总额维持在USD 100,000，注册股本总数为1,000,000,000股，每股面值USD 0.0001，与上月保持一致。
月报指出，报告期末公司已发行普通股股数为782,178,180股，库存股份9,576,900股，总计791,755,080股，较上月底无任何新增发行、购回或注销变动。公司确认已符合相关最低公众持股量要求，股本及已发行股份数保持稳定，未发生调整。
该报告由公司董事王晓洁签署。公司同时表示，将继续严格遵守香港联交所《上市规则》及相关法规。另据公告，未有新的股份期权或股权激励计划变动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.